Close

View Older Stories View More Recent Stories

Oct 17, 2011 09:51AM Canaccord Genuity on Life Sciences/Biotechnology: FDA �Flexibility� May Add To Advantages of Orphan Drugs in Today's Market
Oct 17, 2011 08:39AM Canaccord Genuity reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Encouraging Data Points Picked Up During Management/Investor Meeting
Oct 17, 2011 08:37AM Canaccord Genuity Maintains a 'Hold' on Westport Innovations (WPRT); Powering Up the Portfolio Part II: Analyst Day Notes
Oct 17, 2011 08:35AM Canaccord Genuity Maintains a 'Buy' on ICF International (ICFI); Q3 Earnings Preview
Oct 17, 2011 08:33AM Canaccord Genuity Maintains a 'Sell' on Aixtron (AIXG); Cutting Estimates & Price Target
Oct 17, 2011 08:30AM UPDATE - Canaccord Genuity Downgraded Veeco Instruments (VECO) to 'Sell' on Cut in Forecasts
Oct 17, 2011 08:12AM Canaccord Genuity Upgrades Minefinders Corp. (MFN) to Buy
Oct 17, 2011 07:27AM Canaccord Genuity Downgrades Veeco Instruments Inc. (VECO) to Sell
Oct 14, 2011 09:06AM Canaccord Genuity Reiterates a 'Buy' on Tranzyme (TZYM); Ulimorelin Phase 3 Enrollment Progressing Well
Oct 14, 2011 09:04AM Canaccord Genuity Maintains a 'Hold' on Micromet (MITI); B-mab Development Plan Solidifies
Oct 14, 2011 09:02AM Canaccord Genuity Reiterates a 'Buy' on Medicis (MRX); Takeout Speculation Likely to Continue
Oct 13, 2011 08:26AM Canaccord Genuity on Consumer & Retail/Footwear and Apparel: Does the NBA Lockout Really Matter?
Oct 13, 2011 08:24AM Canaccord Genuity Reiterates a 'Buy' on Solta Medical (SLTM); Notes From the Road
Oct 13, 2011 08:23AM Canaccord Genuity Reiterates a 'Buy' on Meridian Biosciences (VIVO); Thesis Review Following Road Trip
Oct 13, 2011 08:21AM Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Management Meeting Takeaways: Nuedexta European MAA on Track for Year-End Filing
Oct 13, 2011 08:20AM Canaccord Genuity Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); Settlement with Bayer Removes Big Overhang
Oct 13, 2011 08:18AM Canaccord Genuity Maintains an 'Buy' on Schnitzer Steel (SCHN); August Quarter Earnings Preview
Oct 13, 2011 07:04AM Microsemi (MSCC) Completes Zalink Acquisition, Extends Tender Offer
Oct 12, 2011 08:55AM Canaccord Genuity Life Sciences/Specialty Pharmaceuticals: Three Catalysts With Potential To Drive Upside by Year-End - TEVA, WCRX & WPI
Oct 12, 2011 08:51AM Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Hallo Esbriet: New German Pricing Process May Let Other Countries Delay Pricing
Oct 12, 2011 08:49AM Canaccord Genuity Maintains a 'Buy' on Inhibitex (INHX); Big Catalysts Expected Over Next 12 Months
Oct 12, 2011 08:47AM Canaccord Genuity Maintains a 'Buy' on Jones Lang LaSalle (JLL); Reducing Estimates on Slower Real Estate Market Growth
Oct 12, 2011 07:26AM Canaccord Genuity Downgrades Lloyds TSB Group (LYG) to Hold
Oct 11, 2011 11:26AM Canaccord Genuity on Life Sciences -- Biomedical Devices and Services: CQ3/11 Med-Tech Preview
Oct 11, 2011 10:40AM Notable Analyst Rating Changes 10/11: (NUE) (SFD) (ARO) Upgraded; (COP) (PDLI) (STP) Downgraded
Oct 11, 2011 09:13AM Canaccord Genuity Starts Mylan (MYL) at Hold
Oct 11, 2011 09:13AM Canaccord Genuity Starts Perrigo Co. (PRGO) at Hold
Oct 11, 2011 09:13AM Canaccord Genuity Starts Impax Laboratories (IPXL) at Hold
Oct 11, 2011 08:41AM Canaccord Genuity Maintains a 'Buy' on IMRIS (IMRS); Lowering Estimates and Price Target
Oct 11, 2011 08:39AM Canaccord Genuity Maintains a 'Hold' on RPC Inc. (RES); Still Pricing in Some Acquisition Potential
Oct 11, 2011 08:36AM Canaccord Genuity maintains a 'Buy' on EOG Resources (EOG); Liquids Growth on Track; Potential Value Uplift from Improving Price Realizations
Oct 10, 2011 09:34AM Research in Motion (RIMM) volatility stays elevated at 79
Oct 10, 2011 08:45AM Canaccord Genuity on Life Sciences/Biotechnology: Maintains 'Buy' on MNTA & WPI
Oct 10, 2011 08:39AM Canaccord Genuity Reiterates a 'Hold' on Research In Motion (RIMM); Checks Indicate Solid Initial BB 7 Sales; L-T Concerns Make Premium Take-Out Valuation Unlikely
Oct 10, 2011 08:37AM Canaccord Genuity Reiterates a 'Buy' on Apple (AAPL); Checks Indicate Strong Initial iPhone 4S Pre-orders, Legacy Model Sales
Oct 10, 2011 08:35AM Canaccord Genuity Maintains a 'Buy' on Pioneer Natural Resources (PXD); Production Momentum Bodes Well for Q3/11; Strong Hedge Position
Oct 7, 2011 08:38AM Canaccord Genuity maintains a 'Buy' on Cytokinetics (CYTK); A closer look - CK357 Dizziness: May Not Be Dealbreaker in ALS
Oct 7, 2011 08:34AM Canaccord Genuity Reiterates a 'Buy' on AngioDynamics (ANGO); Good Start for New CEO
Oct 7, 2011 08:33AM Canaccord Genuity Downgrades GLG Life Tech Corporation (GLGL) to Hold; No Longer Stomaching the Aftertaste of Consistent Disappointment
Oct 7, 2011 08:30AM Canaccord Genuity Reiterates a 'Buy' on Oracle (ORCL); Best Positioned Platform Vendor
Oct 7, 2011 08:29AM Canaccord Genuity Reiterates a 'Buy' on Anaren (ANEN); Soft Wireless Sales and Push-out of Space & Defense Contracts Force Pre-Announcement
Oct 6, 2011 08:35AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Catalysts Ahead
Oct 6, 2011 08:33AM Canaccord Genuity Reiterates a 'Buy' on Raptor Pharmaceuticals (RPTP); Cystinosis Doctor Call Takeaways: ~5x Better Compliance, Patient Outcomes Possible with RP103
Oct 6, 2011 08:31AM Canaccord Genuity Reiterates a 'Buy' on Onyx Pharmaceuticals (ONXX); C-Mib Reg Catalysts Ahead
Oct 6, 2011 08:29AM Canaccord Genuity Reiterates a 'Buy' on Integra LifeSciences (IART); Ascension Acquisition Complete; Unique Technology & Broadens Market
Oct 6, 2011 08:27AM Canaccord Genuity Maintains a 'Hold' on LKQ Corp (LKQX); Raising 2012 Estimates on ECP Acquisition
Oct 6, 2011 08:25AM Canaccord Genuity Reiterates a 'Buy' on Apple (AAPL); Thesis Fully Intact Despite Death of Legend
Oct 6, 2011 08:23AM Canaccord Genuity Maintains a 'Hold' on Baker Hughes (BHI); Attractive After Declines, but Peers Cheaper
Oct 5, 2011 08:46AM Canaccord Genuity Reiterates a 'Buy' on Quidel Corp. (QDEL) After Meeting With Management
Oct 5, 2011 08:42AM Canaccord Genuity Maintains a 'Buy' on Kadant; Lowering Numbers on More Conservative Outlook
View More Recent Stories View Older Stories